Company: ATIIU
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001437749-25-025722
Chunk: 63

Company: Archimedes Tech SPAC Partners II Co.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 63
---
$2,597,582  $920,219 
 Denominator:                 
 Basic weighted-average shares outstanding   23,000,000   6,590,000   17,535,912   6,212,265 
 Basic net income per ordinary share  $0.08  $0.08  $0.15  $0.15 

       For the Three Months  Ended June 30,    For the Six Months  Ended June 30,  
   2025    2025  
   Redeemable    Non- Redeemable    Redeemable    Non- Redeemable  
 Diluted net income per share:                 
 Numerator:                 
 Allocation of net income  $1,833,298  $525,280  $2,578,685  $939,116 
 Denominator:                 
 Diluted weighted-average shares outstanding   23,000,000   6,590,000   17,535,912   6,386,298 
 Diluted net income per ordinary share  $0.08  $0.08  $0.15  $0.15 

       For the Period from June 7,  2024 (Inception) Through June 30, 2024  
   Redeemable    Non- Redeemable  
 Basic and diluted net loss per share:         
 Numerator:         
 Allocation of net loss  $—  $(42,700)
 Denominator:         
 Basic and diluted weighted-average shares outstanding   —   5,000,000 
 Basic and diluted net loss per ordinary share  $—  $(0.01)

       10

   ARCHIMEDES TECH SPAC PARTNERS II CO. NOTES TO CONDENSED FINANCIAL STATEMENTS  JUNE 30, 2025 (UNAUDITED)

   Fair Value of Financial Instruments
    
   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
    
   Fair Value Measurement
    
   The fair value of the Company’s financial assets and liabilities reflects management’s